ClinicalTrials.gov has a list of federally and privately funded clinical studies conducted in the United States and around the world.
NIAID has long recognized that racial and ethnic differences affect susceptibility to infection and disease. For example, African Americans account for about 13 percent of the U.S. population, yet represent almost half of new AIDS diagnoses. Native Americans experience higher rates of meningitis and invasive bacterial disease from Haemophilus influenzae type B (Hib) than do other groups. Year after year, asthma has a disproportionate affect on inner-city populations, particularly among African American and Hispanic/Latino children.
NIAID is committed to helping reduce gaps in health among minorities.
NIAID is committed to research that helps reduce these and other health disparities. Its efforts have led to the development of better drugs for HIV/AIDS, vaccines that have almost eliminated Hib-related disease, and educational programs and other interventions to improve asthma control among inner-city children.
NIAID also works to attract minorities to careers in biomedical research through programs such as Intramural NIAID Research Opportunities, which provides training in NIAID labs for undergraduate, graduate, and medical students from underrepresented groups, and Research Centers in Minority Institutions, which is partly funded by NIAID and aims to enhance research infrastructure at minority colleges and universities that offer doctorates in health sciences.
HIV Antibodies Block Infection by Reservoir-Derived Virus in Laboratory Study—Aug. 26, 2014
At AIDS 2014, Dr. Anthony S. Fauci Discusses Key Challenges in HIV Scientific Discovery: Cure, Vaccine—July 21, 2014
Media Availability: HIV Cure Research: Where We Are, Where We Are Headed—July 19, 2014
Media Availability: NIH Scientists Establish Proof-of-Concept for Host-Directed Tuberculosis Therapy—June 26, 2014
News from NIAID-Supported Institutions
Last Updated August 28, 2014